# Post COVID-19 Syndrome and the Gut-lung Axis

> **NCT04813718** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Medical University of Graz** · enrollment: 20 (estimated)

## Conditions studied

- Covid19

## Interventions

- **DIETARY_SUPPLEMENT:** Omni-Biotic Pro Vi 5
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT04813718
- **Lead sponsor:** Medical University of Graz
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-06-02
- **Primary completion:** 2022-07-11
- **Final completion:** 2025-12
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2025-11-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04813718

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04813718, "Post COVID-19 Syndrome and the Gut-lung Axis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04813718. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*